| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 142.34B | 143.39B | 163.22B | 156.05B | 156.52B | 161.70B |
| Gross Profit | 13.72B | 13.14B | 7.61B | 11.99B | 15.19B | 15.10B |
| EBITDA | 5.99B | 6.71B | 97.00M | 6.27B | 10.88B | 10.62B |
| Net Income | 3.45B | 3.69B | -2.07B | 2.91B | 5.99B | 6.26B |
Balance Sheet | ||||||
| Total Assets | 142.09B | 149.84B | 165.08B | 170.66B | 169.62B | 170.90B |
| Cash, Cash Equivalents and Short-Term Investments | 27.48B | 21.67B | 17.53B | 28.07B | 19.78B | 28.21B |
| Total Debt | 6.87B | 6.92B | 13.02B | 6.98B | 7.56B | 14.30B |
| Total Liabilities | 71.91B | 76.78B | 96.16B | 97.42B | 95.13B | 96.77B |
| Stockholders Equity | 68.61B | 71.54B | 67.66B | 72.15B | 73.65B | 73.48B |
Cash Flow | ||||||
| Free Cash Flow | 6.21B | 11.30B | -13.32B | 11.49B | 3.35B | -11.77B |
| Operating Cash Flow | 6.29B | 11.78B | -11.54B | 12.86B | 5.54B | -4.36B |
| Investing Cash Flow | -493.00M | -876.00M | -996.00M | 758.00M | -2.19B | -8.89B |
| Financing Cash Flow | -3.25B | -6.62B | 1.73B | -5.43B | -11.97B | 11.05B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥80.84B | 12.33 | ― | 3.55% | 8.02% | 64.54% | |
67 Neutral | ¥74.48B | 11.22 | ― | 2.56% | 1.71% | 14.20% | |
65 Neutral | ¥52.16B | 9.11 | ― | 2.84% | 15.45% | 43.95% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥68.79B | 7.46 | ― | 3.84% | -8.79% | ― | |
61 Neutral | ¥74.08B | 26.09 | ― | 0.79% | -8.53% | -83.61% | |
48 Neutral | ¥73.35B | -149.33 | ― | 2.73% | -3.59% | 49.34% |